首页> 中文期刊> 《中国组织工程研究》 >自体外周血干细胞移植治疗肌萎缩侧索硬化患者9例:短期效果分析

自体外周血干细胞移植治疗肌萎缩侧索硬化患者9例:短期效果分析

         

摘要

背景:目前临床报道已有关于自体骨髓有核细胞、嗅细胞、脐血源干细胞移植治疗肌萎缩侧索硬化的报道.目的:观察自体外周血干细胞移植治疗9例肌萎缩侧索硬化患者的临床疗效.方法:采用自身前后对照研究方法,对9例肌萎缩侧索硬化患者自体外周血干细胞移植前和移植后第1,3,6个月神经功能改变(FIM、Norris、Bathel评分)及肌电图改变进行评估.结果与结论:自体外周血干细胞移植后自我症状改善,神经功能评分显著高于移植前,短期内效果明显,肌电图呈现改善趋势.结果初步表明自体外周血干细胞移植治疗可在一定程度上改善肌萎缩侧索硬化患者神经功能障碍.%BACKGROUND: At present, there are some clinical reports about the treatment of amyotrophic lateral sclerosis (ALS) by transplantation of autologous bone marrow nucleated cells, olfactory cells and umbilical cord blood-derived stem cells. OBJECTIVE: To evaluate clinical effect of peripheral blood mononuclear cells transplantation on the treatment of 9 ALS patients. METHODS: The changes of neurological function (Norris, FIM, Bathel score) and electromyogram (EMG) changes of 9 ALS patients were evaluated by before-after self control study at the 1st, 3rd, 6th months after peripheral blood mononuclear cells transplantation.RESULTS AND CONCLUSION: After peripheral blood mononuclear cells transplantation, the symptom was improved, neurological scores were significantly higher than pre-transplant, short-term effect was obvious and the EMG showed improvement trend. The results showed that peripheral blood mononuclear cells transplantation has valid short-term effect on improving the neurological dysfunction of ALS patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号